A.MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturer(s) responsible for batch release
Swensweg 5, Postbus 552, 2003 RN Haarlem
TEVA Pharmaceutical Works Private Limited Company
- Temozolomide teva - Teva B.V.
- Clopidogrel teva pharma (clopidogrel hcs) - Teva B.V.
- Sildenafil teva - Teva B.V.
Prescription drugs listed. Manufacturer: "Teva B.V. "
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
- Docetaxel kabi - L01CD02
- Docetaxel teva pharma - L01CD02
- Taxotere - L01CD02
- Docetaxel winthrop - L01CD02
- Taxespira (docetaxel hospira uk limited ) - L01CD02
Prescription drugs listed. ATC Code: "L01CD02"
•Periodic Safety Update Reports
The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European Medicines
D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
•Risk Management Plan (MRP)
•Obligation to conduct